Search research articles
Contact Us
Filters
Showing results (1-10 of 233) with videos related to
Page
of 24
Sort By:
Archives of Cardiovascular Diseases
|
November 3, 2024
Should SGLT2 inhibitors be prescribed after myocardial infarction with left ventricular dysfunction?
Etienne Puymirat
Circulation. Cardiovascular Interventions
|
January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial"
Etienne Puymirat, Nicolas Danchin
Circulation. Cardiovascular Interventions
|
January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial"
Etienne Puymirat, Nicolas Danchin
Revista Espanola De Cardiologia
|
October 4, 2011
[1980-2010: the three glorious decades of cardiology. A comprehensive and collective effort rewarded by outstanding clinical results]
Nicolas Danchin, Etienne Puymirat
Anatolian Journal of Cardiology
|
April 2, 2019
Chest pain after a cesarean -section with a puzzling ECG
Etienne Puymirat, Vincent Aidant
Heart (British Cardiac Society)
|
November 19, 2011
Efficacy and safety of a routine invasive strategy in non-ST segment elevation acute coronary syndromes according to age: an illustration of the difficulty in using combined endpoints with different clinical significance
Nicolas Danchin, Etienne Puymirat
Clinical Cardiology
|
December 9, 2017
An unusual myopericarditis
Clotilde Bailleul, Etienne Puymirat
Presse Medicale (Paris, France : 1983)
|
March 12, 2019
[PCSK9 inhibitors: What place in the management of dyslipidemia?]
Pierre Sabouret, Michel Farnier, Etienne Puymirat
Archives of Cardiovascular Diseases
|
December 7, 2024
Long-term clinical outcomes in patients with acute myocardial infarction with multivessel disease and complete revascularization: Insights from the FLOWER-MI trial, the FRAME-AMI trial and the FAST-MI 2015 registry
Thibault Remy, Nicolas Danchin, Etienne Puymirat
Circulation
|
May 23, 2018
Response by Puymirat et al to Letter Regarding Article, "Acute Myocardial Infarction Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015"
Etienne Puymirat, Tabassome Simon, Nicolas Danchin, et al.
Page
of 24
Search research articles
Search
Showing results (1-10 of 233) with videos related to
Sort By:
Page
of 24
Archives of Cardiovascular Diseases
|
November 3, 2024
Should SGLT2 inhibitors be prescribed after myocardial infarction with left ventricular dysfunction?
Etienne Puymirat
Circulation. Cardiovascular Interventions
|
January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial"
Etienne Puymirat, Nicolas Danchin
Circulation. Cardiovascular Interventions
|
January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial"
Etienne Puymirat, Nicolas Danchin
Revista Espanola De Cardiologia
|
October 4, 2011
[1980-2010: the three glorious decades of cardiology. A comprehensive and collective effort rewarded by outstanding clinical results]
Nicolas Danchin, Etienne Puymirat
Anatolian Journal of Cardiology
|
April 2, 2019
Chest pain after a cesarean -section with a puzzling ECG
Etienne Puymirat, Vincent Aidant
Heart (British Cardiac Society)
|
November 19, 2011
Efficacy and safety of a routine invasive strategy in non-ST segment elevation acute coronary syndromes according to age: an illustration of the difficulty in using combined endpoints with different clinical significance
Nicolas Danchin, Etienne Puymirat
Clinical Cardiology
|
December 9, 2017
An unusual myopericarditis
Clotilde Bailleul, Etienne Puymirat
Presse Medicale (Paris, France : 1983)
|
March 12, 2019
[PCSK9 inhibitors: What place in the management of dyslipidemia?]
Pierre Sabouret, Michel Farnier, Etienne Puymirat
Archives of Cardiovascular Diseases
|
December 7, 2024
Long-term clinical outcomes in patients with acute myocardial infarction with multivessel disease and complete revascularization: Insights from the FLOWER-MI trial, the FRAME-AMI trial and the FAST-MI 2015 registry
Thibault Remy, Nicolas Danchin, Etienne Puymirat
Circulation
|
May 23, 2018
Response by Puymirat et al to Letter Regarding Article, "Acute Myocardial Infarction Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015"
Etienne Puymirat, Tabassome Simon, Nicolas Danchin, et al.
Page
of 24